# PGV

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pgv

- Industry: Healthcare IT
- Headquarters: Tokyo, Japan
- Website: www.pgv.co.jp
- Total disclosed funding: $5.7M
- Latest round: Series A (Jul 14, 2020)
- Investors on record: 8

## About

Based in Japan, PGV Inc. specializes in developing high-precision wearable electroencephalography (EEG) technology, facilitating advanced brainwave measurement and AI analysis to support neuroscience research and applications.Founded in 2016 and headquartered in Tokyo, Japan, PGV Inc. focuses on wearable EEG technology. The company has completed five deals, with its most recent funding round being a Series B in August 2021, raising JPY 300 million from investor SHIONOGI. PGV’s current valuation is JPY 3,039.882 million.PGV Corporation offers high-precision wearable electroencephalography (EEG) technology, developed by Professor Sekiya of Osaka University’s Institute of Industrial Science. Their core product focuses on brainwave measurement and subsequent AI analysis, which serves to visualize and quantify brain activity. This innovative technology is aimed at a wide range of applications, including emotional classification research, sleep analysis, and brain-computer interface (BCI) development. The company's EEG measurement tools and associated services are primarily targeted at academic institutions, healthcare providers, and research organizations, allowing them to conduct advanced studies in neuroscience and mental health. PGV operates in various international markets, catering to clients in North America and Europe, as well as local Japanese markets.PGV generates revenue through a structured model that includes the sale of EEG devices and subscriptions to their AI-based analysis service, NAIS Entry. The company engages in B2B transactions, primarily targeting research institutions and healthcare organizations that require sophisticated EEG data analysis for their studies. Clients purchase EEG measurement devices while subscribing to NAIS Entry for ongoing data analytics support, allowing PGV to maintain a steady revenue stream from both hardware sales and software subscriptions. Specific pricing plans for individual products and services are not publicly disclosed; however, the comprehensive nature of their offerings positions them as a specialized provider in the neuroscience field.With the JPY 300 million raised in Series B funding in August 2021, PGV plans to strengthen its research and development activities and promote further business growth. The company is also focused on expanding its reach into new international markets and enhancing its product offerings with innovative EEG technologies. Specific timelines for product launches and market entry have not been publicly disclosed.

## Funding rounds

- Series A, Jul 14, 2020, $1.4M — Osaka University Venture Capital
- Series A, Jan 28, 2020, $1.2M — Osaka University Venture Capital, NOK, NIKKAN INDUSTRIES
- Series A, Sep 29, 2017, $3.1M — Mitsubishi UFJ Capital, SMBC Venture Capital, Mizuho Capital, Senshu Ikeda Capital, Osaka University Venture Capital, NIPPON MEKTRON, LTD.

## Investors

- Mitsubishi UFJ Capital (https://capitalatlas.ai/funds/mitsubishi-ufj-capital) — Series A
- SMBC Venture Capital (https://capitalatlas.ai/funds/smbc-venture-capital) — Series A
- Mizuho Capital (https://capitalatlas.ai/funds/mizuho-capital) — Series A
- Senshu Ikeda Capital (https://capitalatlas.ai/funds/senshu-ikeda-capital) — Series A
- Osaka University Venture Capital (https://capitalatlas.ai/funds/osaka-university-venture-capital) — Series A
- NIPPON MEKTRON, LTD. — Series A
- NOK — Series A
- NIKKAN INDUSTRIES — Series A